SIGN UP
LOG IN
E
EQ
Equillium
0.71
0.32+81.59%After Hours: 0.5730 -0.14 -19.30%19:59 08/01 EDT
OPEN/PREV CLOSE0.4000/0.3910
TODAY RANGE0.3702-1.360
VOL144.39M
MARKET CAP25.36M
52 WEEK RANGE0.2700-1.500
AVG VOL (3M)3.13M
% TURNOVER404.25%
TURNOVER--
P/E (TTM)-1.8020
% RANGE253.15%
EPS(TTM)-0.3940
P/E(FORWARD)-0.8353
P/B2.398
BVPS0.2961
DIVIDEND--
P/S0.6143
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP16.17M
SHARES OUTSTANDING35.72M
NEXT EARNINGS08/06-08/11
FREE FLOAT22.77M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Benzinga·21h ago
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga·1d ago
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga·07/22 21:06
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga·07/01 21:05
12 Health Care Stocks Moving In Tuesday's After-Market Session
TipRanks·06/13 20:40
Equillium Granted Extension for Nasdaq Compliance
Benzinga·06/11 21:05
12 Health Care Stocks Moving In Wednesday's After-Market Session
TipRanks·05/22 21:53
Equillium Holds Annual Stockholders Meeting on Key Proposals
TipRanks·04/24 17:21
Leerink says Equillium’s itolizumab news ‘disappointing but not surprising’
NASDAQ·04/24 13:50
FDA Declines Breakthrough Therapy Status For Equillium's Itolizumab
TipRanks·04/24 13:11
Equillium says FDA declines Breakthrough Therapy designation for itolizumab
Reuters·04/24 13:06
EQUILLIUM INC - FDA OPEN TO EVALUATING LONGER TERM OUTCOMES FOR ITOLIZUMAB
Dow Jones·03/28 11:52
Equillium Cut to Market Perform From Outperform by Leerink Partners
Dow Jones·03/28 11:52
Equillium Price Target Cut to $1.00/Share From $3.00 by Leerink Partners
Same Industry
Name/Symbol
Change%
Price
Contact Us
Contact Number : +852 3852 8500Service Email : service@webull.hkBusiness Cooperation : marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.